CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-24 | GUINAN MARK Executive Vice President & CFO | Grant or award | +2,251 | 88,676 | ||
| 2022-02-24 | GUINAN MARK Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +10,932 | 10,932 | ||
| 2022-02-24 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −1,669 | $126.26 | $211K | 37,144 |
| 2022-02-24 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +2,741 | 39,885 | ||
| 2022-02-24 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +13,301 | 13,301 | ||
| 2022-02-24 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +3,915 | 32,346 | ||
| 2022-02-24 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +7,830 | 40,176 | ||
| 2022-02-24 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award · Non-Qualifed Stock Option (right to buy) | +19,009 | 19,009 | ||
| 2022-02-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −7,463 | $130.09 | $971K | 276,964 |
| 2022-02-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −2,255 | $130.23 | $294K | 274,709 |
| 2022-02-23 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −933 | $130.09 | $121K | 39,219 |
| 2022-02-23 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −406 | $130.23 | $53K | 38,813 |
| 2022-02-23 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −219 | $130.09 | $28K | 26,640 |
| 2022-02-23 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −94 | $130.23 | $12K | 26,727 |
| 2022-02-23 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −1,673 | $130.09 | $218K | 87,119 |
| 2022-02-23 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −694 | $130.23 | $90K | 86,425 |
| 2022-02-23 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −1,082 | $130.09 | $141K | 67,647 |
| 2022-02-23 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −492 | $130.23 | $64K | 67,155 |
| 2022-02-23 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Shares withheld for taxes | −1,712 | $130.09 | $223K | 48,219 |
| 2022-02-23 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Shares withheld for taxes | −724 | $130.23 | $94K | 47,495 |
Page 33 of 42 · 826 trades